Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection.
Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3) Collaborative. Geddes L, et al. Among authors: lloyd ar. Clin Infect Dis. 2020 Jan 1;70(1):123-131. doi: 10.1093/cid/ciz162. Clin Infect Dis. 2020. PMID: 30816419 Free PMC article.
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
Post JJ, Pan Y, Freeman AJ, Harvey CE, White PA, Palladinetti P, Haber PS, Marinos G, Levy MH, Kaldor JM, Dolan KA, Ffrench RA, Lloyd AR, Rawlinson WD; Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group. Post JJ, et al. Among authors: lloyd ar. J Infect Dis. 2004 May 15;189(10):1846-55. doi: 10.1086/383279. Epub 2004 Apr 26. J Infect Dis. 2004. PMID: 15122521
Protective immunity against hepatitis C virus infection.
Elliot LN, Lloyd AR, Ziegler JB, Ffrench RA. Elliot LN, et al. Among authors: lloyd ar. Immunol Cell Biol. 2006 Jun;84(3):239-49. doi: 10.1111/j.1440-1711.2006.01427.x. Immunol Cell Biol. 2006. PMID: 16509830 Review.
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group. Dore GJ, et al. Among authors: lloyd ar. Gastroenterology. 2010 Jan;138(1):123-35.e1-2. doi: 10.1053/j.gastro.2009.09.019. Epub 2009 Sep 24. Gastroenterology. 2010. PMID: 19782085 Free PMC article.
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M; ATAHC Study Group. Grebely J, et al. Among authors: lloyd ar. Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015. Drug Alcohol Depend. 2010. PMID: 19926405 Free PMC article. Clinical Trial.
289 results